Slash Your Lung Cancer Risk in HALF

By Dr. Richard Gerhauser, M.D. Posted September 25, 2017

Dear Reader,

A few weeks ago, I told you about a landmark study that puts another nail in the cholesterol/heart disease myth. The study revealed two critical pieces of information:

1. That lowering cholesterol did not lower the risk of having a second cardiovascular event
2. That the key to lowering the risk of a future heart attack was in fact reducing inflammation in the body

It was an exciting day for doctors like me who have been railing against the cholesterol deception for decades.

But this study is turning out to be the gift that keeps on giving.

Because buried in the data from this study was another groundbreaking finding that could change how we treat another leading cause of death: cancer.

First, a recap. The study included over 10,000 people who had had a previous heart attack, and who all had high levels of “high sensitivity C-reactive protein” (hsCRP), which is a standard marker of inflammation.

The patients received an anti-inflammatory drug called canakinumab for four years.

In the end, the people who experienced the greatest reductions in inflammation (as measured by the hsCRP) experienced a remarkable 30 percent reduction in their risk of having a second heart attack, stroke, or even dying from a cardiovascular event.

But there’s more to this story.

The researchers knew that inflammation also plays a role in cancer, so they formed a committee of cancer experts to specifically evaluate any cancer-related benefits that might occur in the study.

And once again, actively reducing inflammation had REMARKABLE health benefits… this time, it slashed the rate of cancer deaths in HALF!

It was particularly effective against lung cancer—decreasing both the incidence of lung cancer and deaths caused by lung cancer.

This makes perfect sense. Toxins from things like cigarette smoke and air pollution are highly inflammatory, and can cause inflammation in the lungs that directly increases the risk of lung cancer.

As an added benefit, the participants also experienced significant reductions in osteoarthritis, arthritis, and gout—three conditions that are known to be driven by inflammation.

The connection between inflammation and cancer (and virtually every other disease) has been known for YEARS. But the mainstream has been slow to acknowledge its role… likely because there hasn’t been a drug that can impact inflammation to this extent.

So should you be actively taking steps to lower your levels of inflammation? Yes!

Should you be doing it with a drug? No way!

One of nature’s most powerful anti-inflammatory substances is the spice turmeric. If you’re not taking it already, it’s a great addition to your supplement regimen.

Just make sure you take it with black pepper, since it makes it much more bioavailable.

To a brighter day,

Dr. Richard Gerhauser, M.D.

Written By Dr. Richard Gerhauser, M.D.

For years he’s been the trusted doctor for celebrities, world-class athletes, and countless seniors looking to reclaim their health.

And now…for the first time ever… he’s making his medical breakthroughs available to readers all across America.

Dr. Richard Gerhauser, M.D. is one of the most pioneering and innovative minds in medicine today – and he delivers cutting-edge cures each month through his Natural Health Response newsletter.

Natural Health Response readers get full access to Dr. Gerhauser’s protocols for chronic pain… heart disease… diabetes… Alzheimer’s… and even cancer. These are the very same treatments Dr. Gerhauser recommends to his own patients at his practice in Tucson, Arizona.

In addition to being a board-certified medical doctor, Dr. Gerhauser has earned two master’s degrees and has served as a clinical professor at the University of Arizona.

And as a physician at the world-famous Canyon Ranch, Dr. Gerhauser treated celebrities from around the world who paid dearly for the type of next-generation health information he provides Natural Health Response readers each month.

View More By Dr. Richard Gerhauser, M.D.